SCHEMBL6467556

SCHEMBL6467556

COc1ccc(CNC(=O)c2n[nH]cc2NC(N)=O)c(OC)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.51
TAS1R3 Q7RTX0 2/20 0.51
TAS1R1 Q7RTX1 2/20 0.51
TSHR P16473 2/20 0.51
NPSR1 Q6W5P4 2/20 0.51
GAA P10253 3/20 0.50
HTT P42858 2/20 0.50
HPGD P15428 2/20 0.50
PKM P14618 1/20 0.50
ROCK2 O75116 1/20 0.48
KMT2A Q03164 2/20 0.47
MAPT P10636 3/20 0.47
MAOB P27338 1/20 0.47
NAMPT P43490 1/20 0.46
MEN1 O00255 1/20 0.45
MAPK1 P28482 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HSD17B10 Q99714 1/20 0.45
KDM4E B2RXH2 1/20 0.44
NPC1 O15118 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2264852 0.84 ALDH1A1 (0.55) ALDH1A1TAS1R3TAS1R1TSHRNPSR1
Hydrochloric Acid SCHEMBL2267196 0.84 ALDH1A1 (0.54) ALDH1A1TAS1R3TAS1R1TSHRNPSR1
SCHEMBL6501353 0.83 L3MBTL1 (0.50) ALDH1A1TSHRHPGDKMT2AMAPT
SCHEMBL13556407 0.83 ALDH1A1 (0.58) ALDH1A1TAS1R3TAS1R1TSHRNPSR1
SCHEMBL12961919 0.81 ALDH1A1 (0.54) ALDH1A1TAS1R3TAS1R1TSHRNPSR1
SCHEMBL2267405 0.80 ALDH1A1 (0.52) ALDH1A1TAS1R3TAS1R1TSHRNPSR1
SCHEMBL3361891 0.77 APLNR (0.63) ALDH1A1TAS1R3TAS1R1TSHRNPSR1
SCHEMBL2267394 0.77 MAPT (0.52) ALDH1A1TAS1R3TAS1R1TSHRNPSR1
SCHEMBL6497717 0.77 KDM4C (0.49) ALDH1A1TAS1R3TAS1R1TSHRNPSR1
SCHEMBL4886080 0.74 ROCK2 (0.63) ALDH1A1TAS1R3TAS1R1TSHRNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation PHARMACIA AND UPJOHN COMPANY LLC 2005-09-08 US disclosed
WO-2005037797-A1 SUBSTITUTED PYRAZOLE UREA COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2005-04-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation IL4, ARG2, CASP4 ALDH1A1 846/4885TAS1R3 425/4885TAS1R1 597/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.